May 15, 2025 · STOCK Act disclosure
Representative Robert P. Bresnahan, Jr. (Republican-PA) bought Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on May 15, 2025 and was disclosed on June 9, 2025 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.